Neurocrine Biosciences (NBIX) Enterprise Value (QoQ) (2010 - 2026)
Neurocrine Biosciences (NBIX) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.38% |
| Mar 31, 2026 | 11.09% |
| Dec 31, 2025 | -32.80% |
| Sep 30, 2025 | -14.27% |
| Jun 30, 2025 | -3.40% |
| Mar 31, 2025 | 12.32% |
| Dec 31, 2024 | 12.37% |
| Sep 30, 2024 | -18.20% |
| Jun 30, 2024 | 14.18% |
| Mar 31, 2024 | -16.45% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | -12.12% |
| Jun 30, 2023 | -9.18% |
| Mar 31, 2023 | 10.28% |
| Dec 31, 2022 | -24.73% |
| Sep 30, 2022 | -23.31% |
| Jun 30, 2022 | 2.50% |
| Mar 31, 2022 | 6.94% |
| Dec 31, 2021 | 6.71% |
| Sep 30, 2021 | 13.45% |